First-in-Human Safety, Tolerability, and Pharmacokinetics of Single-Dose Kukoamine B Mesylate in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Phase I Study

被引:0
作者
Hongzhong Liu
Qian Zhao
Yuping Yuan
Zhenlei Wang
Teng Wang
Wei Tian
Wen Zhong
Ji Jiang
Shuai Chen
Kai Kong
Chunyan Jin
Pei Hu
机构
[1] Peking Union Medical College Hospital,Clinical Pharmacology Research Center, State Key Laboratory of Complex Severe and Rare Diseases, NMPA Key Laboratory for Clinical Research and Evaluation of Drug, Beijing Key Laboratory of Clinical PK and PD Investigat
[2] Chinese Academy of Medical Sciences & Peking Union Medical College,Clinical Research Center for Innovative Drugs
[3] Tianjin Chasesun Pharmaceutical Co.,undefined
[4] Ltd.,undefined
来源
Infectious Diseases and Therapy | 2024年 / 13卷
关键词
Kukoamine B; Phase I trial; Pharmacokinetic; Safety;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:361 / 371
页数:10
相关论文
共 75 条
[1]  
Singer M(2016)The third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA 315 801-810
[2]  
Deutschman CS(2021)Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 Intensive Care Med 47 1181-1247
[3]  
Seymour CW(2020)Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study The Lancet 395 200-211
[4]  
Shankar-Hari M(2012)Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes Expert Rev Anti Infect Ther 10 701-706
[5]  
Annane D(2020)The epidemiology of sepsis in Chinese ICUs: a national cross-sectional survey Crit Care Med 48 e209-e218
[6]  
Bauer M(2018)Sepsis and septic shock The Lancet 392 75-87
[7]  
Evans L(2021)Intracellular and extracellular lipopolysaccharide signaling in sepsis: avenues for novel therapeutic strategies J Innate Immun 13 323-332
[8]  
Rhodes A(2010)Circulating mitochondrial DAMPs cause inflammatory responses to injury Nature 464 104-107
[9]  
Alhazzani W(2016)Kukoamine B promotes TLR4-independent lipopolysaccharide uptake in murine hepatocytes Oncotarget 7 57498-57513
[10]  
Antonelli M(2015)A novel role of kukoamine B: Inhibition of the inflammatory response in the livers of lipopolysaccharide-induced septic mice via its unique property of combining with lipopolysaccharide Exp Ther Med 9 725-732